tiprankstipranks
Infant Bacterial Therapeutics AB (DE:9IB)
BERLIN:9IB
Germany Market

Infant Bacterial Therapeutics AB (9IB) Balance Sheet

Compare
4 Followers

Infant Bacterial Therapeutics AB Balance Sheet

Infant Bacterial Therapeutics AB's total assets for Q4 2024 were kr239.57M, an increase of 0.11% from the previous quarter. DE:9IB total liabilities were kr69.30M for the fiscal quarter, a 96.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
kr 351.33Mkr 349.62Mkr 408.48Mkr 450.32Mkr 518.27M
Total Liabilities
kr 46.18Mkr 17.91Mkr 13.22Mkr 10.16Mkr 7.88M
Total Equity Gross Minority
kr 305.15Mkr 331.71Mkr 395.25Mkr 440.15Mkr 510.40M
Other Metrics
Currency in SEK

Infant Bacterial Therapeutics AB Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis